| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Lock Kenneth A. is a Chief Commercial Officer at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 | ARQT Arcutis Biotherapeutics, Inc. | Chief Commercial Officer | Sell | 831 | $15.26 | $12,684.05 | -1.3% | -41.1% | -25.0% | |
| Mar 2, 2023 | ARQT Arcutis Biotherapeutics, Inc. | Chief Commercial Officer | Sell | 2,368 | $15.96 | $37,795.95 | -1.8% | -52.5% | -25.6% | |
| Mar 7, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Chief Commercial Officer | Sell | 1,023 | $16.85 | $17,234.43 | -1.1% | +24.5% | -17.1% | |
| Mar 1, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Chief Commercial Officer | Sell | 935 | $17.75 | $16,598.77 | -2.9% | +19.3% | -4.6% | |
| Mar 1, 2021 | ARQT Arcutis Biotherapeutics, Inc. | Chief Commercial Officer | Sell | 933 | $34.20 | $31,907.76 | -4.0% | -21.6% | -50.0% |